LaChapelle Robin
SEC insider (Form 3/4/5 filer). CIK 0002009136. Chief Operating Officer at ArriVent BioPharma, Inc. (AVBP). 10 reported Form 4/5 transactions since Sep 2024; latest on Feb 2, 2026. Located in NEWTOWN SQUARE, PA.
Companies LaChapelle Robin has filed insider reports for
- ArriVent BioPharma, Inc. (AVBP): Officer, Chief Operating Officer
LaChapelle Robin
CIK: 0002009136
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ArriVent BioPharma, Inc.
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Feb 2, 2026AVBP
ArriVent BioPharma, Inc.
AwardDirectStock Option (right to buy)
130K shares- - Jul 11, 2025AVBP
ArriVent BioPharma, Inc.
ExerciseDirect2.6K shares at avg. $2.28$6K - Jul 11, 2025AVBP
ArriVent BioPharma, Inc.
ExerciseDirect6.5K shares at avg. $2.28$15K - Jul 11, 2025AVBP
ArriVent BioPharma, Inc.
ExerciseDirect2.1K shares at avg. $2.28$5K - Feb 3, 2025AVBP
ArriVent BioPharma, Inc.
AwardDirectStock Option (right to buy)
120K shares- - Sep 19, 2024AVBP
ArriVent BioPharma, Inc.
ExerciseDirect2.9K shares at avg. $2.28$7K - Sep 19, 2024AVBP
ArriVent BioPharma, Inc.
ExerciseDirect7.2K shares at avg. $2.28$16K - Sep 19, 2024AVBP
ArriVent BioPharma, Inc.
ExerciseDirect2.5K shares at avg. $2.28$6K - Sep 19, 2024AVBP
ArriVent BioPharma, Inc.
ExerciseDirect12.4K shares at avg. $3.65$45K - Sep 19, 2024AVBP
ArriVent BioPharma, Inc.
ExerciseDirect2.7K shares at avg. $6.24$17K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 2, 2026 | AVBP ArriVent BioPharma, Inc. | Award Stock Option (right to buy) | 130,000 | - | - | Direct |
| Jul 11, 2025 | AVBP ArriVent BioPharma, Inc. | Exercise | 2,600 | $2.28 | $5,928 | Direct |
| Jul 11, 2025 | AVBP ArriVent BioPharma, Inc. | Exercise | 6,503 | $2.28 | $14,827 | Direct |
| Jul 11, 2025 | AVBP ArriVent BioPharma, Inc. | Exercise | 2,050 | $2.28 | $4,674 | Direct |
| Feb 3, 2025 | AVBP ArriVent BioPharma, Inc. | Award Stock Option (right to buy) | 120,000 | - | - | Direct |
| Sep 19, 2024 | AVBP ArriVent BioPharma, Inc. | Exercise | 2,867 | $2.28 | $6,537 | Direct |
| Sep 19, 2024 | AVBP ArriVent BioPharma, Inc. | Exercise | 7,164 | $2.28 | $16,334 | Direct |
| Sep 19, 2024 | AVBP ArriVent BioPharma, Inc. | Exercise | 2,471 | $2.28 | $5,634 | Direct |
| Sep 19, 2024 | AVBP ArriVent BioPharma, Inc. | Exercise | 12,364 | $3.65 | $45,129 | Direct |
| Sep 19, 2024 | AVBP ArriVent BioPharma, Inc. | Exercise | 2,700 | $6.24 | $16,848 | Direct |
1-10 of 10 transactions